Overview

• Five children regained hearing after receiving AAV-based gene therapy in both ears.
• The therapy targets mutations in the OTOF gene, essential for transmitting sound signals.
• Children showed improved speech perception and ability to locate sounds in noisy environments.
• The trial, conducted in Shanghai and Boston, marks the first bilateral application of this therapy.
• Researchers aim to expand trials and seek FDA approval for broader use.